(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|
Turnover | --133.01M | -6.39%700.62M | 63.73%748.48M | 94.35%190.04M | 101.49%457.14M | --97.78M | -37.99%226.88M | --365.88M |
Operating income | 133.01M | -6.39%700.62M | 63.73%748.48M | 94.35%190.04M | 101.49%457.14M | 97.78M | -37.99%226.88M | 365.88M |
Cost of sales | ---132.24M | 10.99%-524.87M | -78.90%-589.67M | -83.93%-154.64M | -50.57%-329.61M | ---84.07M | 14.00%-218.9M | ---254.54M |
Operating expenses | -132.24M | 10.99%-524.87M | -78.90%-589.67M | -83.93%-154.64M | -50.57%-329.61M | -84.07M | 14.00%-218.9M | -254.54M |
Gross profit | 770K | 10.67%175.75M | 24.52%158.8M | 158.29%35.4M | 1,497.69%127.53M | 13.71M | -92.83%7.98M | 111.34M |
Selling expenses | ---20.83M | -20.39%-59.33M | -114.30%-49.28M | -61.11%-13.68M | -187.19%-23M | ---8.49M | -16.31%-8.01M | ---6.88M |
Administrative expenses | ---113.5M | -37.66%-249.69M | 70.57%-181.39M | -83.84%-76.53M | -310.06%-616.25M | ---41.63M | -385.16%-150.28M | ---30.98M |
Research and development expenses | ---65.3M | -64.59%-151.12M | -27.18%-91.82M | -77.55%-49.15M | -100.84%-72.19M | ---27.68M | -3.59%-35.95M | ---34.7M |
Impairment and provision | ---44.55M | -67.50%-164.4M | -6.21%-98.14M | -235.84%-26.18M | -362.38%-92.4M | ---7.8M | -623.01%-19.98M | ---2.76M |
-Other impairment is provision | ---44.55M | -67.50%-164.4M | -6.21%-98.14M | -235.84%-26.18M | -362.38%-92.4M | ---7.8M | -623.01%-19.98M | ---2.76M |
Special items of operating profit | --35.45M | 1,082.21%49.92M | -245.20%-5.08M | -2,285.45%-12.92M | -51.90%3.5M | --591K | -33.03%7.28M | --10.87M |
Operating profit | -207.96M | -49.44%-398.87M | 60.33%-266.9M | -100.64%-143.05M | -238.16%-672.81M | -71.3M | -524.38%-198.96M | 46.88M |
Financing income | --4.71M | 22.74%12.67M | 8.60%10.32M | -17.74%3.54M | 1,083.44%9.5M | --4.3M | 392.64%803K | --163K |
Financing cost | ---10.77M | 40.83%-10.13M | 31.64%-17.11M | 21.66%-9.72M | 0.48%-25.03M | ---12.41M | 0.23%-25.15M | ---25.21M |
Share of profits of associates | --90K | -100.61%-40.09M | ---19.99M | ---- | ---- | ---- | ---- | ---- |
Share of profit from joint venture company | ---- | ---- | ---- | -307.45%-766K | -813.69%-6.61M | ---188K | 14.64%-723K | ---847K |
Earning before tax | -213.94M | -48.60%-436.42M | 57.74%-293.68M | -88.46%-150M | -210.20%-694.95M | -79.59M | -1,167.38%-224.03M | 20.99M |
Tax | --1.64M | 114.06%28.8M | 266.16%13.45M | -166.65%-1.42M | -402.88%-8.1M | --2.13M | 973.49%2.67M | --249K |
After-tax profit from continuing operations | -212.3M | -45.46%-407.62M | 60.14%-280.23M | -95.48%-151.42M | -217.60%-703.04M | -77.46M | -1,142.28%-221.36M | 21.24M |
Earning after tax | -212.3M | -45.46%-407.62M | 60.14%-280.23M | -95.48%-151.42M | -217.60%-703.04M | -77.46M | -1,142.28%-221.36M | 21.24M |
Minority profit | ---- | 53.38%-3.18M | -20,739.39%-6.81M | -817.23%-2.72M | 100.51%33K | ---296K | -50,153.85%-6.53M | ---13K |
Profit attributable to shareholders | -212.3M | -47.92%-404.45M | 61.11%-273.42M | -92.71%-148.71M | -227.28%-703.08M | -77.17M | -1,110.90%-214.83M | 21.25M |
Basic earnings per share | -0.41 | -31.94%-0.95 | 67.71%-0.72 | -61.54%-0.42 | -114.42%-2.23 | -0.26 | -1,045.45%-1.04 | 0.11 |
Diluted earnings per share | -0.41 | -31.94%-0.95 | 67.71%-0.72 | -61.54%-0.42 | -114.42%-2.23 | -0.26 | -1,045.45%-1.04 | 0.11 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data